Guardant Health expands FDA-approved companion diagnostic use for HERNEXEOS

FDA grants priority review for Genentech's Tecentriq in stage III dMMR/MSI-H colon cancer

Formosa Pharmaceuticals signs Vietnam licensing deal with Samil Pharmaceuticals

Harbour BioMed IND for HBM7004 accepted by China's NMPA

Organon secures FDA approval expanding TOFIDENCE indications for CRS and paediatric COVID-19

FDA grants rare paediatric disease designation to RedHill's opaganib

GSK to acquire Nuvalent for USD10.6bn to expand lung cancer portfolio

Galmed Pharmaceuticals to acquire Colospan for GI-focused platform development

Alvotech reports FDA review acceptance for Entyvio biosimilar candidate AVT16

Sanofi secures EU approval for subcutaneous Sarclisa with on-body injector

Bayer reports positive Phase III FIND-CKD results for Kerendia in non-diabetic chronic kidney disease

Gilead and Lakefront complete Ouro Medicines acquisition to expand autoimmune disease pipeline

Lupin's Ranluspec (ranibizumab) injection receives US FDA approval

Pharming secures FDA acceptance of Joenja filing for children with APDS

ADC Therapeutics reports trial results for ZYNLONTA - rituximab combination in relapsed or refractory diffuse large B-Cell lymphoma